InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-22.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Smith Jason Drew. Officer active across 1 company, notably UroGen Pharma Ltd.. Aggregated, 13 reports have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €38k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 1 February 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Smith Jason Drew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,500 sharesOrdinary SharesSEC:0001437749-26-003778:0
3,333 sharesOrdinary SharesSEC:0001437749-25-028705:0
16,500 sharesOrdinary SharesSEC:0001437749-25-023963:0
2,500 sharesOrdinary SharesSEC:0001437749-25-002685:0
3,333 sharesOrdinary SharesSEC:0001437749-24-029038:0
417 shares@ US$15.788.6% of flowOrdinary SharesSEC:0001437749-24-003155:0
834 sharesOrdinary SharesSEC:0001437749-24-003018:0
8,334 sharesOrdinary SharesSEC:0001437749-23-025204:0
833 sharesOrdinary SharesSEC:0001437749-23-002338:0
8,333 sharesOrdinary SharesSEC:0001437749-22-021776:0
833 sharesOrdinary SharesSEC:0001209191-22-006387:0
8,333 sharesOrdinary SharesSEC:0001209191-21-067440:0
2,500 shares@ US$15.7184.1% of flowCommon StockSEC:0001209191-21-033399:0
Canonical exit: 15 Aug 2021 (T+90)
13 of 13 declarations
About Smith Jason Drew
Smith Jason Drew is a declarant linked to UroGen Pharma Ltd. (XNAS), where he is General Counsel. He has 13 filings in total, and across the 13 sampled filings between 2021-05-18 and 2026-02-11, the reported amounts are EUR 32307 in buys and EUR 6091 in sells, with Levée d'options as the most frequent transaction nature.
